Last reviewed · How we verify
Benzofoline (ESTRADIOL BENZOATE)
Benzofoline (generic name: ESTRADIOL BENZOATE) is a Estrogen drug. It is currently FDA-approved.
Benzofoline is a small molecule. Its modality is classified as a small molecule according to ChEMBL.
At a glance
| Generic name | ESTRADIOL BENZOATE |
|---|---|
| Drug class | Estrogen |
| Target | Adenosine receptor A3, Sex hormone-binding globulin, 5-hydroxytryptamine receptor 2B |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Menopausal Hormones and Sympathetic Activation (PHASE4)
- Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients (PHASE3)
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial (PHASE2)
- Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea (PHASE3)
- Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors (PHASE1,PHASE2)
- A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors (PHASE1)
- Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment (PHASE2)
- Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzofoline CI brief — competitive landscape report
- Benzofoline updates RSS · CI watch RSS
Frequently asked questions about Benzofoline
What is Benzofoline?
Benzofoline (ESTRADIOL BENZOATE) is a Estrogen drug.
What is the generic name of Benzofoline?
ESTRADIOL BENZOATE is the generic (nonproprietary) name of Benzofoline.
What drug class is Benzofoline in?
Benzofoline belongs to the Estrogen class. See all Estrogen drugs at /class/estrogen.
What development phase is Benzofoline in?
Benzofoline is FDA-approved (marketed).
What does Benzofoline target?
Benzofoline targets Adenosine receptor A3, Sex hormone-binding globulin, 5-hydroxytryptamine receptor 2B and is a Estrogen.
Related
- Drug class: All Estrogen drugs
- Target: All drugs targeting Adenosine receptor A3, Sex hormone-binding globulin, 5-hydroxytryptamine receptor 2B
- Therapeutic area: All drugs in Nephrology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing